Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-31

FDA Approved: SILDENAFIL — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves ANI Pharmaceuticals' sildenafil citrate as a generic drug under an original application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sildenafil citrate (Sildenafil citrate)

Snippet

ORIG AP for SILDENAFIL (SILDENAFIL CITRATE)